We are live on
!
Find out more
IACGFIA
IDG-Accel China Growth Fund III Associates Portfolio holdings
AUM
$31.2M
1-Year Est. Return
2.97%
This Fund
S&P 500
This Quarter
Est. Return
-40.8%
1 Year Est. Return
-2.97%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$31.2M
AUM Growth
-$23.7M
(-43%)
Cap. Flow
-$210K
Cap. Flow
% of AUM
-0.67%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
6
New
–
Increased
–
Reduced
1
Closed
–
Top Buys
No buys this quarter
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AIH
Aesthetic Medical International Holdings
AIH
|
+$210K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 35.22% |
| 2 | Technology | 35% |
| 3 | Consumer Discretionary | 23.18% |
| 4 | Consumer Staples | 6.61% |
Similar funds
GII
PC
TK
SA
SGAM
MCP
OEP
EIP
IDG-Accel China Growth Fund III Associates's Q3 2021 Portfolio in Review
As of Q3 2021, IDG-Accel China Growth Fund III Associates held 6 positions worth $31.2M, down 43% from $55M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Trading was light in Q3 2021: portfolio turnover was 0%. IDG-Accel China Growth Fund III Associates opened no new positions and made no exits, leaving the 6-position portfolio largely intact.
By sector, the portfolio is most concentrated in Healthcare at 35% of assets, up from 28% a quarter earlier, followed by Technology and Consumer Discretionary.
- IDG-Accel China Growth Fund III Associates's biggest Q3 2021 reduction was Aesthetic Medical International Holdings, cutting an estimated $210K.
- IDG-Accel China Growth Fund III Associates's ten largest holdings make up 100% of its $31.2M portfolio in Q3 2021.
- IDG-Accel China Growth Fund III Associates opened 0 new positions and closed 0 in Q3 2021.
- IDG-Accel China Growth Fund III Associates's portfolio value fell 43% quarter-over-quarter to $31.2M.
Based on IDG-Accel China Growth Fund III Associates's 13F filing for Q3 2021, filed 15 Nov 2021.